# Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

> clinical trial · VERIFIED · 2026-08-12

Status: ACTIVE_NOT_RECRUITING · Sponsor: Genmab · Condition: Platinum-resistant Ovarian Cancer

- Company: Genmab
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06619236

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.